ArticleActa pharmaceutica Sinica. B2023

An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma.

Qiujun Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.